The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications
Open Access
- 15 February 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (4) , 529-534
Abstract
We address the issue of the role of manganese superoxide dismutase in tumorigenesis by studying a relatively homogeneous group of tumours for the correlation between amount of this anti-oxidant enzyme and prognosis. The clinical outcome of 30 patients affected by glioblastomas whose manganese superoxide dismutase content had been established at the time of first diagnosis is compared. When the survival of patients is stratified according to manganese superoxide dismutase level in the tumour, a link of these levels and prognosis can be observed. Patients with high levels of manganese superoxide dismutase show a median survival time of 6.11 months, while patients whose tumours display a low amount of MnSOD have a median survival time of 12.17 months. To assess the upstream mechanisms that sustain the increase in manganese superoxide dismutase content in brain neuroepithelial tumours, we also studied the expression of p53 in a series of 17 astrocytomas of various grading. In all tested astrocytomas, high manganese superoxide dismutase content is associated with cytoplasmic accumulation of p53. Thus glioblastomas can be divided into two distinct groups on the basis of their content of manganese superoxide dismutase, having 'better' or 'worse' prognosis, respectively. The use of this protein as a marker may help to define therapeutic strategies in the clinical management of glioblastoma.Keywords
This publication has 33 references indexed in Scilit:
- An Intronic NF-kappaB Element Is Essential for Induction of the Human Manganese Superoxide Dismutase Gene by Tumor Necrosis Factor-alpha and Interleukin-1betaDNA and Cell Biology, 1999
- Mitochondria and ApoptosisScience, 1998
- Preparation of a Monoclonal Antibody against Rat MnSOD, Using a COOH-Terminal PeptideBiochemical and Biophysical Research Communications, 1993
- Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resectionBritish Journal of Surgery, 1993
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993
- Early superoxide dismutase alterations during SV40‐transformation of human fibroblastsInternational Journal of Cancer, 1992
- SOD2: A new type of tumor‐suppressor gene?International Journal of Cancer, 1992
- High levels of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell linesFree Radical Biology and Medicine, 1992
- Free radicals, antioxidant enzymes, and carcinogenesisFree Radical Biology and Medicine, 1990
- Messenger RNA for manganese and copper-zinc superoxide dismutases in hepatomas: Correlation with degree of differentiationBiochemical and Biophysical Research Communications, 1989